Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with

Luis Felipe Valenzuela-Garcia1, Yasushi Matsuzawa2, Jaskanwal D S Sara3

  • 1Heart Center, Virgen Macarena Hospital, Avenida Doctor Fedriani, nº 3, 41007, Seville, Spain. lfvgmjrh1@yahoo.es.

Insights

Glycaemic control targets do not predict coronary microvascular function in type 2 diabetes mellitus (T2DM). Age, female gender, and glomerular filtration predict CMD, indicating a need for new prevention strategies for T2DM patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Coronary microvascular dysfunction (CMD) is linked to cardiovascular events in type 2 diabetes mellitus (T2DM).
  • Achieving optimal glycaemic control (HbA1c < 7%) does not always prevent future cardiovascular events in T2DM patients.
  • The study investigates the impact of current HbA1c targets on coronary microcirculatory function and identifies predictors of CMD in T2DM.

Purpose of the Study:

  • To assess the effect of the current HbA1c target on coronary microcirculatory function in T2DM patients.
  • To identify predictive factors for coronary microvascular dysfunction (CMD) in T2DM patients.

Main Methods:

  • 100 T2DM patients and 214 controls with chest pain and non-obstructive coronary artery disease were studied.
  • Coronary blood flow was assessed using adenosine and acetylcholine infusions to evaluate endothelial-independent and -dependent function.
  • T2DM patients were categorized by HbA1c levels: optimal (<7%) vs. suboptimal (≥7%) at catheterization.

Main Results:

  • Prevalence of endothelial-independent and -dependent CMD was similar between optimal and suboptimal glycaemic control groups.
  • Age and female gender predicted endothelial-independent CMD; glomerular filtration predicted endothelial-dependent CMD.
  • Optimal glycaemic control did not significantly associate with either type of CMD.

Conclusions:

  • Current HbA1c targets do not predict improved coronary microcirculatory function in T2DM patients.
  • Predictive factors for CMD in T2DM include age, female gender, and glomerular filtration rate.
  • Effective strategies for preventing CMD in T2DM patients require further investigation.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.1K